Investor mix
6 investors on record; lead investors include Equity Group Investments; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 1 | 17% |
| Other / undisclosed | 4 | 67% |
Human iPSC-derived cells and services for research, drug discovery, and therapy
6 investors on record; lead investors include Equity Group Investments; 2 have since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 17% |
| Private equity | 1 | 17% |
| Other / undisclosed | 4 | 67% |